Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma

Arzneimittel-Forschung/Drug Research

Volumn 57, Issue 2, 2007, Pages 87-91

  Horiguchi, Takahiko ^a   Tachikawa, Soichi ^a   Kondo, Rieko ^a   Miyazaki, Junichi ^a   Shiga, Mamoru ^a   Hirose, Masahiro ^a   Kobayashi, Kashin ^a   Hayashi, Nobuyukl ^a   Ohira, Daisuke ^a   Nasu, Toshinori ^a   Otake, Yoichiro ^a   Hata, Hideharu ^a  

^a FUJITA HEALTH UNIVERSITY BANTANE HOSPITAL   (Japan)

Author keywords

Antiasthmatics; Bronchial asthma, elderly; CAS 103177 37 3; Leukotriene receptor antagonist

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE; PRANLUKAST;

AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL COUNT; EXPIRATORY FLOW; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; SPUTUM;

EID: 33847747446     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296588     Document Type: Article

References (9)

1. nd revised edition. Tokyo: Kyowa Kikaku Tsushin; 2003.
2. Donahue JG, Weiss ST, Livingston LM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277(11):887-891.
3. Ishihara K, Hasegawa T, Nishimura T, Okazaki M, Katakami N, Umeda B. Increased use of inhaled corticosteroids and reduced hospitalizations in adult asthmatics: 11 years' experience in a Japanese hospital. Respirology. 1998;3:193-197.
4. Ishihara K. The present asthma death situation in Japan: Future direction of asthma treatment to decrease asthma deaths. Int Rev Asthma. 2002;4(4):60-66.
5. Horiguchi T, Tachikawa S, Kasahara J, Doi M, Shiga M. Effects of pranlukast hydrate on serum eosinophil cationic protein levels in patients with adult bronchial asthma. Arzneimittel-Forschung (Drug Research). 1999;49(1):35-37.
6. Bootsma GP, Dekhuijzen R, Festen J, Mulder PGH, Swinkels LMJW, Herwaarden CLAV. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate. Am J Respir Crit Care Med. 1997;153:924-930.
7. Horiguchi T, Tachikawa S, Kondo R, Miyazaki J, Sasaki Y, Banno K et al. Evaluation of the combined effect of pranlukast during high-dose steroid inhalation. Arzneimittel-Forschung (Drug Research). 2002;52(11):813-816.
8. Horiguchi T, Tachikawa S, Kondo R, Siga M, Hirose M, Ito T. Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma. Arzneimittel-Forschung (Drug Research). 2003;53(10):714-721.
9. Tanizaki Y, Mitsunobu F, Hosaki Y, Ashida K. IV Allergy and Collagen Diseases: 1.Pathophysiology and treatment of bronchial asthma in elderly patients. Nippon Naika Gakkai Zasshi (Internal Med). 2003;92(3):448-452.